🔴 Recursion Pharmaceuticals is trading 5.63% down today as higher Treasury yields pressure technology stocks

Recursion Pharmaceuticals is trading 5.63% down now at $2.92 as technology stocks weaken amid rising Treasury yields, oil prices, and renewed U.S.-Iran tensions.

• The S&P 500 is down 0.62% and the Nasdaq Composite is down 1.44%, according to the provided market context.
• Reuters reported higher yields pressured technology valuations on August 18, 2026. Morgan Stanley trimmed its price target to $5.30 from $5.50 while maintaining Equalweight; no direct company catalyst was identified.